EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SPARCL1 and NT-proBNP as Biomarkers of Right Ventricular-to-Pulmonary Artery Uncoupling in Pulmonary Hypertension

Oliver Dörr, Stanislav Keranov iD, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J Richter, Henning Gall und 4 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Oliver Dörr und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology, University of Giessen, Giessen, Germany. Hauptthemen laut MEDLINE: Peptide Fragments, Natriuretic Peptide, Brain, Pulmonary Artery, Hypertension, Pulmonary. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N-terminal pro-brain natriuretic protein (NT-proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT-proBNP and SPARCL1 concentrations are associated with load-independent parameters of RV function and RV-to-pulmonary artery (RV–PA) coupling as measured using invasive pressure–volume (PV) loops in the RV.

Methods

SPARCL1 and NT-proBNP were measured in the plasma of patients with idiopathic pulmonary artery hypertension (IPAH, n = 73). Participants without LV or RV abnormalities served as controls (n = 28). All patients underwent echocardiography and right heart catheterization with invasive PV loop measurements.

Results

Our cohort had more females with IPAH than the control group (64% vs. 35%; P = 0.01) and was older [69 (interquartile range, IQR 57–76) vs. 51 (IQR 35–62) years; P < 0.001]. SPARCL1 and NT-proBNP levels were significantly higher in patients with IPAH as compared with controls (P < 0.0001). Patients with IPAH and maladaptive RV remodelling had higher SPARCL1 and NT-proBNP concentrations than those with adaptive RV remodelling (P < 0.01). Both SPARCL1 and NT-proBNP were good predictors of maladaptive RV remodelling in receiver operating characteristic analysis [area under the curve (AUC) (AUCSPARCL1 = 0.75, AUCNT-proBNP = 0.72, P = 0.36 for AUCSPARCL1 vs. AUCNT-proBNP]. The combined predictive value of SPARCL1 and NT-proBNP (AUC 0.78, P < 0.001) for maladaptive RV was numerically higher than that of either SPARCL1 or NT-proBNP alone (P = 0.16 for AUCSPARCL1 + NT-proBNP vs. AUCNT-proBNP and P = 0.18 for AUCSPARCL1 + NT-proBNP vs. AUCSPARC1). SPARCL1 showed numerically a tendency for a better predictive power than NT-proBNP for parameters of early maladaptive RV remodelling such as RV ejection fraction < 50% (AUCSPARCL1 = 0.77, AUCNT-proBNP = 0.67, P = 0.06 for AUCSPARCL1 vs. AUCNT-proBNP), RV end-diastolic diameter > 42 mm (AUCSPARCL1 = 0.72, AUCNT-proBNP = 0.65, P = 0.19 for AUCSPARCL1 vs. AUCNT-proBNP) and RV end-systolic volume index RVESVI > 31 mL/m2 (AUCSPARCL1 = 0.78, AUCNT-proBNP = 0.71, PP = 0.10 for AUCSPARCL1 vs. AUCNT-proBNP).

Conclusions

SPARCL1 and NT-proBNP are good predictors of maladaptive RV remodelling and RV–PA uncoupling in IPAH patients. SPARCL1 may be a better predictor of early maladaptive RV remodelling than NT-proBNP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptide FragmentsNatriuretic Peptide, BrainPulmonary ArteryHypertension, PulmonaryCalcium-Binding ProteinsVentricular Function, RightExtracellular Matrix ProteinsHeart VentriclesVentricular Dysfunction, RightHumansFemaleMaleMiddle AgedBiomarkersAgedAdultEchocardiographyCardiac CatheterizationROC Curve

Stichwörter der Autor:innen

Ees/EaPV loopsRV dysfunctionRV remodellingRV–PA coupling

Substanzen

Peptide FragmentsBiomarkerspro-brain natriuretic peptide (1-76)Natriuretic Peptide, BrainSPARCL1 protein, humanCalcium-Binding ProteinsExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Cardiology and Angiology, University of Giessen, Giessen, Germany.
  • Cardioangiological Center Bethanien (CCB), Frankfurt, Germany.
  • German Center for Cardiovascular Research (DZHK) Partner Site Rhine-Main, Bad Nauheim, Germany.
  • Department of Cardiology, Heart and Vascular Center Bad Segeberg, Bad Segeberg, Germany.
  • Department of Cardiology, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.
  • Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI), Member of the German Center…

ORCID-Profile: Stanislav Keranov

Zitieren

APA

Dörr, O., Keranov, S., van Wickern, P., Nef, H., Hamm, C., Bauer, P., Troidl, C., Sossalla, S., Voss, S., Liebetrau, C., Richter, M. J., Gall, H., Seeger, W., Ghofrani, A., Yogeswaran, A., & Tello, K. (2025). SPARCL1 and NT-proBNP as Biomarkers of Right Ventricular-to-Pulmonary Artery Uncoupling in Pulmonary Hypertension. ESC Heart Failure. https://doi.org/10.1002/ehf2.15159

Vancouver

Dörr O, Keranov S, van Wickern P, Nef H, Hamm C, Bauer P, et al. SPARCL1 and NT-proBNP as Biomarkers of Right Ventricular-to-Pulmonary Artery Uncoupling in Pulmonary Hypertension. ESC Heart Failure. 2025. doi:10.1002/ehf2.15159

BibTeX
@article{Drr2025,
  author = {Dörr, Oliver and Keranov, Stanislav and van Wickern, Paulina and Nef, Holger and Hamm, Christian and Bauer, Pascal and Troidl, Christian and Sossalla, Samuel and Voss, Sandra and Liebetrau, Christoph and Richter, Manuel J and Gall, Henning and Seeger, Werner and Ghofrani, Ardeschir and Yogeswaran, Athiththan and Tello, Khodr},
  title = {SPARCL1 and NT-proBNP as Biomarkers of Right Ventricular-to-Pulmonary Artery Uncoupling in Pulmonary Hypertension},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15159}
}
Kostenlos starten →